A carregar...

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

Piritrexim is a lipid-soluble drug which is as effective an inhibitor of dihydrofolate reductase as methotrexate. Phase I and II studies have indicated activity in some tumour types. Because of its lipophilicity we have conducted a phase II study in recurrent high-grade malignant glioma (grades III...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bleehen, N. M., Newman, H. V., Rampling, R. P., Ramsay, J. R., Roberts, J. T., Bedford, P., Nethersell, A. B.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1995
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033879/
https://ncbi.nlm.nih.gov/pubmed/7669591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!